BioVersys AG Statistics

Total Valuation

BioVersys AG has a market cap or net worth of CHF 174.70 million. The enterprise value is 159.05 million.

Market Cap	174.70M
Enterprise Value	159.05M

Important Dates

The next estimated earnings date is Wednesday, September 10, 2025.

Earnings Date	Sep 10, 2025
Ex-Dividend Date	n/a

Share Statistics

BioVersys AG has 5.82 million shares outstanding.

Current Share Class	5.82M
Shares Outstanding	5.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	4.33%
Float	4.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	144.03
PB Ratio	16.36
P/TBV Ratio	16.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.50
EV / Sales	131.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.19

Financial Position

The company has a current ratio of 3.56, with a Debt / Equity ratio of 1.59.

Current Ratio	3.56
Quick Ratio	3.51
Debt / Equity	1.59
Debt / EBITDA	n/a
Debt / FCF	-1.09
Interest Coverage	-18.20

Financial Efficiency

Return on equity (ROE) is -194.40% and return on invested capital (ROIC) is -44.89%.

Return on Equity (ROE)	-194.40%
Return on Assets (ROA)	-33.87%
Return on Invested Capital (ROIC)	-44.89%
Return on Capital Employed (ROCE)	-74.08%
Revenue Per Employee	44,926
Profits Per Employee	-693,296
Employee Count	27
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	31.43
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.40
Average Volume (20 Days)	5,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioVersys AG had revenue of CHF 1.21 million and -18.72 million in losses. Loss per share was -5.62.

Revenue	1.21M
Gross Profit	1.21M
Operating Income	-18.73M
Pretax Income	-18.72M
Net Income	-18.72M
EBITDA	-18.67M
EBIT	-18.73M
Loss Per Share	-5.62

Full Income Statement

Balance Sheet

The company has 32.62 million in cash and 16.97 million in debt, giving a net cash position of 15.65 million or 2.69 per share.

Cash & Cash Equivalents	32.62M
Total Debt	16.97M
Net Cash	15.65M
Net Cash Per Share	2.69
Equity (Book Value)	10.68M
Book Value Per Share	32.50
Working Capital	24.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.57 million and capital expenditures -38,000, giving a free cash flow of -15.61 million.

Operating Cash Flow	-15.57M
Capital Expenditures	-38,000
Free Cash Flow	-15.61M
FCF Per Share	-2.68

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,544.11%
Pretax Margin	-1,543.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioVersys AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.71%
FCF Yield	-8.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioVersys AG has an Altman Z-Score of -4.1 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.1
Piotroski F-Score	1